Clinic Roundup

March 2012
BioWorld Today;3/20/2012, Vol. 23 Issue 44, p8
The article reports that the study on autologous adipose-derived regenerative cell (ADRC)-enriched fat grafting for reconstruction of the breast after cancer surgery was published by Cytori Therapeutics Inc. in the "Journal of Surgical Oncology."


Related Articles

  • BREAST RECONSTRUCTION STUDY INITIATED IN JAPAN.  // Worldwide Biotech;Jun2006, Vol. 18 Issue 6, p3 

    Reports on the plan of Cytori Therapeutics Inc. to conduct a breast reconstruction study in Japan. Efficacy of using adult adipose derived stem and regenerative cells for breast reconstruction; Use of the company's Celutionâ„¢ system to isolate and concentrate patient stem and regenerative...

  • EU approves start of Cytori study.  // Medical Device Daily;5/14/2008, Vol. 12 Issue 93, p9 

    The article reports on the European Union (EU) approval received by San Diego, California-based Cytori to begin its European stem and regenerative cell-enhanced breast reconstruction study in breast cancer patients who have undergone partial mastectomy. The study is entitled RESTORE II. The...

  • Japanese study eyes breast augmentation.  // Medical Device Daily;11/14/2007, Vol. 11 Issue 219, p8 

    The article describes a study in Japan which will investigate the effect of adult stem and regenerative cells derived from adipose tissue in breast augmentation. The Celution System from Cytori Therapeutics is used to generate cells at the time of surgery. According to the company, adipose...

  • Cytori cites results of Japan study.  // Medical Device Daily;12/26/2007, Vol. 11 Issue 233, p8 

    The article deals with a report presented by Cytori Therapeutics at the San Antonio Breast Cancer Symposium. Cytori said that positive results were received from an independent, investigator sponsored study in Japan in which adipose tissue-derived stem and regenerative cells were used for breast...

  • Cytori Therapeutics Announces Independent Clinical Study Results in Breast Reconstruction Presented at the Association of Breast Surgery Conference.  // Biomedical Market Newsletter;5/17/2011, p619 

    The article offers information on the results of the clinical study conducted by Cytori Therapeutics Inc. regarding the RESTORE procedure. It mentions that the RESTORE procedure, was a fat grafting procedure used in reconstructive breast surgery using Adipose-Derived Regenerative Cell (ADRC). It...

  • Financings roundup.  // Medical Device Daily;6/15/2010, Vol. 14 Issue 114, p2 

    This article reports on the 20 million U.S. dollar loan facility secured by Cytori Therapeutics from GE Capital, Healthcare Financial Services, Oxford Finance Corp. and Silicon Valley Bank.

  • Cytori begins cell therapy study in Japan.  // Medical Device Daily;10/29/2012, Vol. 16 Issue 209, p8 

    The article reports on the approval by the Japan Ministry of Health, Labor and Welfare on two independent investigator-sponsored and funded cell therapy clinical studies of Cytori Therapeutics in the country.

  • Financings roundup.  // Medical Device Daily;10/11/2010, Vol. 14 Issue 197, p3 

    The article reports on the decision of San Diego, California-based Cytori Therapeutics to sell 4 million shares of its common stock for 4.50 U.S. dollar per share.

  • Cytori Pursuing Restructuring Plan. Meiling, Brittany // San Diego Business Journal;9/29/2014, Vol. 35 Issue 39, p9 

    The article reports that San Diego-based cell therapy firm Cytori Therapeutics Inc. has planned to pursue its corporate restructuring plan.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics